Search Results - "ZINAÏ, Amina"
-
1
Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Published in Blood (29-11-2018)“…Background UCART19 is an allogeneic, genetically modified CAR T-cell product (anti-CD19 scFv- 41BB-CD3ζ) manufactured from healthy donor T cells, in which TRAC…”
Get full text
Journal Article -
2
Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Published in Blood (08-12-2017)“…▪ Background UCART19 is a genetically modified T-cell product manufactured from non-HLA matched healthy donor cells and aims to provide a ready to use,…”
Get full text
Journal Article -
3
Intracerebral gene therapy for Sanfilippo syndrome type A
Published in Molecular genetics and metabolism (01-02-2013)Get full text
Journal Article -
4
Inolimomab in steroid-refractory acute graft-versus- host disease following allogeneic hematopoietic stem cell transplantation : Retrospective analysis and comparison with other interleukin-2 receptor antibodies
Published in Transplantation (27-09-2005)“…The use of monoclonal antibodies against interleukin-2 receptor (IL-2R)-alpha chains could be an effective treatment of acute graft-versus-host disease (GvHD)…”
Get full text
Journal Article -
5
Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-in-Human Trial (CALM) in Adult Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Published in Blood (08-12-2017)“…▪ Background UCART19 is a genetically modified T-cell product manufactured from non-HLA matched healthy donor cells. Lentiviral-transduced CAR T-cells express…”
Get full text
Journal Article -
6
Need of Reconsideration of Mobilization Strategy in Autologous Stem Cell Transplantation for Multiple Myeloma: Results of the Positive Impact of High Number of CD34+ Infused Cells
Published in Blood (20-11-2009)“…Abstract 3225 Poster Board III-162 Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cells (PBSC) is widely used in first line treatment…”
Get full text
Journal Article -
7
r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer
Published in Lung cancer (Amsterdam, Netherlands) (01-06-1996)“…Twenty patients with locally advanced or metastatic non-small cell lung cancer entered a study of recombinant human methionyl G-CSF (r-metHuG-CSF) as an…”
Get full text
Journal Article